Core Insights - Newmont Corporation's first-quarter 2025 results indicate significant increases in unit costs, with gold costs applicable to sales rising 16% year over year to $1,227 per ounce and all-in sustaining costs (AISC) reaching $1,651 per ounce, reflecting a 13% sequential and 15% year-over-year increase [1][6] Cost Trends - Newmont expects gold AISC for its total portfolio to be $1,630 per ounce in 2025, up from $1,516 per ounce in 2024, driven by increased direct operating costs and inflation [2][6] - Higher labor costs, which account for about half of Newmont's direct costs, are a significant concern, alongside rising materials and contract services costs [2][6] - The company anticipates unit costs for the second quarter to be similar to or slightly higher than the first quarter due to increased sustaining capital spending, which is expected to peak in the second quarter [2] Peer Comparisons - Barrick Mining Corporation experienced a 22% sequential increase in AISC to $1,775 per ounce, influenced by operational challenges and lower production [3] - Agnico Eagle Mines Limited reported a slight decline in AISC of 0.6% in the first quarter but projects an increase for the remainder of 2025, with total cash costs per ounce expected between $915 and $965 [4] Market Performance - Newmont's shares have increased by 43.2% year to date, compared to a 48.1% rise in the Zacks Mining – Gold industry, largely due to a rally in gold prices [5] - The company is currently trading at a forward 12-month earnings multiple of 12.12, which is approximately 9.6% below the industry average of 13.4X, and holds a Value Score of A [9] Earnings Outlook - The Zacks Consensus Estimate for Newmont's earnings implies a year-over-year rise of 20.1% for 2025 and 11.7% for 2026, with EPS estimates trending higher over the past 60 days [10]

Group 1: Goldman Sachs - Goldman Sachs' shares have outperformed the Zacks Financial - Investment Bank industry over the past year, with a growth of +72.7% compared to +42.6% for the industry [5] - The company's restructuring initiatives are expected to enhance its presence in overseas markets, supported by decent cash levels and a solid credit profile [5][6] - Despite strong earnings performance, the global banking and markets division may face pressure due to capital market volatility and geopolitical concerns [6] Group 2: Progressive Corp. - Progressive's shares have outperformed the Zacks Insurance - Property and Casualty industry over the past year, with a growth of +41.3% compared to +18% for the industry [7] - The company is benefiting from higher premiums and a strong product portfolio, focusing on becoming a one-stop insurance destination [7][8] - However, exposure to catastrophe losses and escalating expenses pose challenges to its margins [9] Group 3: Boston Scientific - Boston Scientific's shares have outperformed the Zacks Medical - Products industry over the past year, with a growth of +60.2% compared to +13.9% for the industry [10] - The company is experiencing strong demand across its MedSurg and Cardiovascular lines, with positive contributions from acquisitions [10][11] - Despite macroeconomic concerns, the company expects strong organic growth in 2025, although rising costs and foreign exchange headwinds are significant risks [12] Group 4: Cooper-Standard Holdings Inc. - Cooper-Standard's shares have declined -3.9% over the past year, while the Zacks Automotive - Original Equipment industry has seen a decline of -9.2% [13] - The company achieved a 96.8% year-over-year increase in adjusted EBITDA to $54.3 million, driven by cost optimizations [13] - However, high debt levels and rising interest costs present risks, alongside challenges from weak global auto production and pricing pressures [15]